Molecure
Pre-clinicalA biotechnology company developing small molecule therapies targeting RNA and protein-protein interactions for oncology and inflammatory diseases.
Founded
2015
Focus
Small Molecules
About
A biotechnology company developing small molecule therapies targeting RNA and protein-protein interactions for oncology and inflammatory diseases.
Funding History
3Total raised: $27.7M
IPO$15.2MUndisclosedJun 15, 2022
Series A$10MUndisclosedJun 15, 2021
Grant$2.5MEuropean UnionJun 15, 2020
Company Info
TypePrivate
Founded2015
LocationWarsaw, Poland
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
AILIS Breast Cancer
Pre-clinical · Warsaw
Biocam
Pre-clinical · Warsaw
Bioton
Pre-clinical · Warsaw
Ensera
Pre-clinical · Warsaw
Biovico
Pre-clinical · Warsaw
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile